Live webinar on Prostate Cancer next WED July 1st at 2PM PST
It is said that 70% of men over 70 have prostate cancer. Does telomerase activation impact the incidence, severity, or recurrence?
It is said that 70% of men over 70 have prostate cancer. Does telomerase activation impact the incidence, severity, or recurrence?
Doctors are seldom allowed and even less frequently motivated to deviate from standard of care, which frowns upon removing the dandelion (the primary cancer of origin) after the seeds have spread (the distant metastases).
DISCLAIMER: This website is for educational purposes only and is not for advertising. Telomerase activators and nanovesicles are not FDA-approved to prevent or treat any disease and anecdotes are not scientific proof of efficacy. All patients were treated in the context of a fully informed and legally-protected patient physician relationship.
Required fields
© 2020 Recharge Biomedical
Exosomes and TA-65 are not FDA-approved to prevent or treat any illness